These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7171571)

  • 1. Conformational analysis of small disulfide loops. Spectroscopic and theoretical studies on a synthetic cyclic tetrapeptide containing cystine.
    Venkatachalapathi YV; Prasad BV; Balaram P
    Biochemistry; 1982 Oct; 21(22):5502-9. PubMed ID: 7171571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide models for the redox-active disulfide loop of glutaredoxin. Conformational studies.
    Kishore R; Raghothama S; Balaram P
    Biochemistry; 1988 Apr; 27(7):2462-71. PubMed ID: 3382633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive beta-turn conformation of a synthetic model peptide corresponding to the active site of thioredoxin.
    Ravi A; Balaram P
    Biochim Biophys Acta; 1983 Jun; 745(3):301-9. PubMed ID: 6860677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation and dynamics of a cyclic disulfide-bridged peptide: effects of temperature and solvent.
    Li F; Bravo-Rodriguez K; Phillips C; Seidel RW; Wieberneit F; Stoll R; Doltsinis NL; Sanchez-Garcia E; Sander W
    J Phys Chem B; 2013 Apr; 117(13):3560-70. PubMed ID: 23514118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
    Bélec L; Blankenship JW; Lubell WD
    J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution and solid state conformational preferences of a family of cyclic disulphide bridged tetrapeptides.
    Berger N; Li F; Mallick B; Brüggemann JT; Sander W; Merten C
    Biopolymers; 2017 Jan; 107(1):28-34. PubMed ID: 27606951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of (Boc-Cys/Sec-NHMe)
    Dolle A; Reddy KKA; Gunaga SS; Krishnamurthy K; Senapati DK; Rana A; Sindogi K; Biswal HS; Raghothama S; Gowd KH
    J Pept Sci; 2020 Apr; 26(4-5):e3245. PubMed ID: 32103604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of cyclolinopeptide A, a cyclic nonapeptide: nuclear Overhauser effect and energy minimization studies.
    Raghothama S; Ramakrishnan C; Balasubramanian D; Balaram P
    Biopolymers; 1989 Feb; 28(2):573-88. PubMed ID: 2713453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpectedly fast cis/trans isomerization of Xaa-Pro peptide bonds in disulfide-constrained cyclic peptides.
    Shi T; Spain SM; Rabenstein DL
    J Am Chem Soc; 2004 Jan; 126(3):790-6. PubMed ID: 14733553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure and solution conformation of S,S'-bis(Boc-Cys-Ala-OMe): intramolecular antiparallel beta-sheet conformation of an acyclic cystine peptide.
    Raj PA; Soni SD; Ramasubbu N; Bhandary KK; Levine MJ
    Biopolymers; 1990; 30(1-2):73-85. PubMed ID: 2224052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent-induced beta-hairpin to helix conformational transition in a designed peptide.
    Awasthi SK; Shankaramma SC; Raghothama S; Balaram P
    Biopolymers; 2001 Apr; 58(5):465-76. PubMed ID: 11241218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and conformation of the disulfide bond in dimeric lung surfactant peptides SP-B1-25 and SP-B8-25.
    Biswas N; Waring AJ; Walther FJ; Dluhy RA
    Biochim Biophys Acta; 2007 May; 1768(5):1070-82. PubMed ID: 17349612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptide models for protein secondary structures. Beta-sheet formation in acyclic cystine peptides.
    Balaram H; Uma K; Balaram P
    Int J Pept Protein Res; 1990 Jun; 35(6):495-500. PubMed ID: 2401590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferred conformations of cyclic Ac-Cys-Pro-Xaa-Cys-NHMe peptides: a model for chain reversal and active site of disulfide oxidoreductase.
    Park HS; Kim C; Kang YK
    Biophys Chem; 2003 Aug; 105(1):89-104. PubMed ID: 12932582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-helical cyclic peptides: design, synthesis, and crystal structure of figure-eight mirror-image conformers of adamantane-constrained cystine-containing cyclic peptide cyclo (Adm-Cyst)(3).
    Ranganathan D; Haridas V; Nagaraj R; Karle IL
    J Org Chem; 2000 Jul; 65(14):4415-22. PubMed ID: 10891146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
    Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
    Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystine peptides. Antiparallel beta-sheet conformation of the cyclic biscystine peptide [Boc-Cys-Ala-Cys-NHCH3]2.
    Karle IL; Flippen-Anderson JL; Kishore R; Balaram P
    Int J Pept Protein Res; 1989 Jul; 34(1):37-41. PubMed ID: 2793307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics study of disulfide bond influence on properties of an RGD peptide.
    Wang Y; Goh SY; Kuczera K
    J Pept Res; 1999 Feb; 53(2):188-200. PubMed ID: 10195456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.
    Atkinson RA; Pelton JT
    FEBS Lett; 1992 Jan; 296(1):1-6. PubMed ID: 1309703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.